Research & Literature

Non-Infectious Uveitis: Optimising the Therapeutic Response.

Airody A, Heath G, Lightman S, Gale R

Drugs 2016; (76(1)):27-39 doi:10.1007/s40265-015-0502-y.

Factors Influencing Aqueous Proinflammatory Cytokines and Growth Factors in Uveitic Glaucoma.

Ohira S, Inoue T, Iwao K, et al.

PloS one 2016; (11(1)):e0147080 doi:10.1371/journal.pone.0147080.

Patterns of Uveitis in a Tertiary Care Referral Institute in Saudi Arabia.

Al Dhibi HA, Al Shamsi HN, Al-Mahmood AM, et al.

Ocular immunology and inflammation 2017; (25(3)):388-395 doi:10.3109/09273948.2015.1133836.

Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Grajewski RS, Boelke AC, Adler W, et al.

Eye (London, England) 2016; (30(11)):1415-1423 doi:10.1038/eye.2016.133.

The Pattern of Uveitis among Chinese, Malays, and Indians in Singapore.

Siak J, Jansen A, Waduthantri S, et al.

Ocular immunology and inflammation 2017; (25(sup1)):S81-S93 doi:10.1080/09273948.2016.1188968.

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.

Nguyen QD, Merrill PT, Jaffe GJ, et al.

Lancet (London, England) 2016; (388(10050)):1183-92.

Coping with psychosomatic symptoms: The buffering role of psychological flexibility and impact on quality of life.

Leonidou C, Panayiotou G, Bati A, Karekla M

Journal of health psychology 2019; (24(2)):175-187 doi:10.1177/1359105316666657.

[Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].

Wang Y, Yang L, Zhang ZL

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2016; (48(5)):910-914.

Clinical Patterns and Causes of Intraocular Inflammation in a Uveitis Patient Cohort from Egypt.

Amin RM, Goweida M, Bedda A, et al.

Ocular immunology and inflammation 2019; (27(6)):859-867 doi:10.1080/09273948.2016.1236972.

Roles of interleukin-17 in uveitis.

Guedes MC, Borrego LM, Proença RD

Indian journal of ophthalmology 2016; (64(9)):628-634 doi:10.4103/0301-4738.194339.

A Rare Case of Tubulointerstitial Nephritis and Uveitis Syndrome Treated with a Multi-Specialty Approach.

Purt B, Hiremath S, Smith S, et al.

The American journal of case reports 2016; (17()):869-873 doi:10.12659/ajcr.900701.

Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case.

Kalogeropoulos D, Kitsos G, Konstantinidis A, et al.

The American journal of case reports 2017; (18()):367-374 doi:10.12659/ajcr.903304.

Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.

Amer R, Alsughayyar W, Almeida D

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2017; (255(7)):1423-1432 doi:10.1007/s00417-017-3667-0.

Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis.

Sardar E, Dusser P, Rousseau A, et al.

The Journal of pediatrics 2017; (186()):131-137.e1 doi:10.1016/j.jpeds.2017.03.052.

Patterns of uveitis in children at the apex institute for eye care in India: analysis and review of literature.

Takkar B, Venkatesh P, Gaur N, et al.

International ophthalmology 2018; (38(5)):2061-2068 doi:10.1007/s10792-017-0700-6.

[Prognostic factors in uveitis].

Albaroudi N, Tijani M, Boutimzine N, et al.

Journal francais d'ophtalmologie 2017; (40(9)):751-757 doi:10.1016/j.jfo.2017.04.005.

Cataract Surgery Complications in Uveitis Patients: A Review Article.

Llop SM, Papaliodis GN

Seminars in ophthalmology 2018; (33(1)):64-69 doi:10.1080/08820538.2017.1353815.

Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications.

Han YS, Rivera-Grana E, Salek S, Rosenbaum JT

JAMA ophthalmology 2018; (136(2)):109-115 doi:10.1001/jamaophthalmol.2017.5466.

Multifocal choroiditis as the first sign of systemic sarcoidosis associated with pembrolizumab.

Lise QK, Audrey AG

American journal of ophthalmology case reports 2017; (5()):92-93 doi:10.1016/j.ajoc.2016.12.014.

Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review.

Ming S, Xie K, He H, et al.

Drug design, development and therapy 2018; (12()):2005-2016 doi:10.2147/DDDT.S160431.

Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group.

Arevalo JF, Lasave AF, Gupta V, et al.

Ocular immunology and inflammation 2019; (27(8)):1296-1304 doi:10.1080/09273948.2018.1523436.

Reclassifying Idiopathic Uveitis: Lessons From a Tertiary Uveitis Center.

Choi RY, Rivera-Grana E, Rosenbaum JT

American journal of ophthalmology 2019; (198()):193-199 doi:10.1016/j.ajo.2018.10.018.

[Application of TNF-alpha inhibitors in treatment of uveitis associated with ankylosing spondylitis].

Razumova IY, Godzenko AA

Vestnik oftalmologii 2018; (134(5. Vyp. 2)):257-262 doi:10.17116/oftalma2018134051257.

Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.

Takeuchi M, Kanda T, Kaburaki T, et al.

Medicine 2019; (98(9)):e14668 doi:10.1097/MD.0000000000014668.

Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.

Gangaputra SS, Newcomb CW, Joffe MM, et al.

American journal of ophthalmology 2019; (208()):68-75 doi:10.1016/j.ajo.2019.07.008.

Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.

Rathinam SR, Gonzales JA, Thundikandy R, et al.

JAMA 2019; (322(10)):936-945 doi:10.1001/jama.2019.12618.

Relationship of Epiretinal Membrane Formation and Macular Edema Development in a Large Cohort of Uveitic Eyes.

Mustafi D, Do BK, Rodger DC, Rao NA

Ocular immunology and inflammation 2021; (29(5)):915-921 doi:10.1080/09273948.2019.1704026.

[Treatment of ocular tuberculosis-an update].

Brönnimann LC, Zimmerli S, Garweg JG

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2020; (117(11)):1080-1086 doi:10.1007/s00347-020-01099-1.

Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial.

Axelsson E, Andersson E, Ljótsson B, et al.

JAMA psychiatry 2020; (77(9)):915-924 doi:10.1001/jamapsychiatry.2020.0940.

New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.

Valenzuela RA, Flores I, Urrutia B, et al.

Frontiers in pharmacology 2020; (11()):655 doi:10.3389/fphar.2020.00655.

Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis.

Leclercq M, Langlois V, Girszyn N, et al.

Journal of autoimmunity 2020; (113()):102481 doi:10.1016/j.jaut.2020.102481.

Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.

Kong CL, Kelly NK, Sundararajan M, et al.

Ocular immunology and inflammation 2022; (30(1)):198-202 doi:10.1080/09273948.2020.1774906.

Adalimumab in the treatment of non-infectious uveitis.

Burek-Michalska A, Turno-Kręcicka A

Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2020; (29(10)):1231-1236 doi:10.17219/acem/125431.

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study.

Pacella E, Loffredo L, Malvasi M, et al.

Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):3611-3617 doi:10.2147/OPTH.S265691.

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis.

Favalli EG, Bugatti S, Klersy C, et al.

Arthritis research & therapy 2020; (22(1)):290 doi:10.1186/s13075-020-02395-6.

Stalagmite-like pre-retinal deposits in the optical coherence tomography of two vitrectomy patients with panuveitis.

Calles Monar PS, Sanabria Ruiz-Colmenares MR, Cano Suárez MT, et al.

Archivos de la Sociedad Espanola de Oftalmologia 2021; doi:10.1016/j.oftal.2020.12.014.

Cost-Utility Analysis of Mycophenolate Mofetil versus Methotrexate for Noninfectious Uveitis.

Al-Khersan H, Fowler BJ, Clauss KD, et al.

Ophthalmology. Retina 2021; (5(12)):1281-1282 doi:10.1016/j.oret.2021.08.004.

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience.

Tang Lee Say TL, Yang V, Fingret JM, et al.

BMJ open ophthalmology 2021; (6(1)):e000819 doi:10.1136/bmjophth-2021-000819.

Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.

Tsui E, Rathinam SR, Gonzales JA, et al.

Ophthalmology 2022; (129(6)):661-667 doi:10.1016/j.ophtha.2022.02.002.

Stalagmite-like pre-retinal deposits in the optical coherence tomography of two vitrectomy patients with panuveitis.

Calles Monar PS, Sanabria Ruiz-Colmenares MR, Cano Suárez MT, et al.

Archivos de la Sociedad Espanola de Oftalmologia 2022; (97(2)):104-108 doi:10.1016/j.oftale.2020.12.015.

Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Sagris M, Theofilis P, Antonopoulos AS, et al.

Biomedicines 2022; (10(2)) doi:10.3390/biomedicines10020242.

Use of systemic corticosteroids in patients newly registered at a claims database with a diagnosis of non-infectious uveitis: results from a real-world claims database analysis.

Umazume A, Ohguro N, Okada AA, et al.

Japanese journal of ophthalmology 2022; (66(4)):394-404 doi:10.1007/s10384-022-00923-2.

Pattern and Visual Prognostic Factors of Behcet's Uveitis in Northwest Iran.

Alizadeh Ghavidel L, Bagheri M, Mousavi F, et al.

Journal of ophthalmic & vision research 2022; (17(2)):242-251 doi:10.18502/jovr.v17i2.10796.

Types of Fundus Involvement in Intraocular Tuberculosis.

Kaya M, Ömeroglu Şimşek G, Ucan ES, et al.

Turkish thoracic journal 2022; (23(5)):322-330 doi:10.5152/TurkThoracJ.2022.21207.

OPTICAL COHERENCE TOMOGRAPHY FEATURES IN IDIOPATHIC NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIS.

Felfeli T, Eshtiaghi A, Tai F, et al.

Retina (Philadelphia, Pa.) 2022; (42(11)):2143-2149 doi:10.1097/IAE.0000000000003572.

[Sarcoid uveitis: Ophthalmologist's and internist's viewpoints].

Sève P, Jacquot R, El Jammal T, et al.

La Revue de medecine interne 2023; (44(3)):112-122 doi:10.1016/j.revmed.2022.10.001.

Treatment of Non-Infectious Posterior Uveitis with Dexamethasone Intravitreal Implants in a Real-World Setting.

Butt F, Devonport H

Clinical ophthalmology (Auckland, N.Z.) 2023; (17()):601-611 doi:10.2147/OPTH.S393662.

Diagnosis and treatment of tuberculosis presenting as uveitis based on stochastic simulation in systems biology.

Liu L, Gou Y, Chen L, Zong Z

Biotechnology & genetic engineering reviews 2024; (40(4)):4098-4107 doi:10.1080/02648725.2023.2205197.

Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis.

Gupta RB, Ilin J, Gottlieb CC

Journal of ophthalmic inflammation and infection 2023; (13(1)):42 doi:10.1186/s12348-023-00360-3.

Protective role of IL-17-producing γδ T cells in a laser-induced choroidal neovascularization mouse model.

Chang YH, Hsing CH, Chiu CJ, et al.

Journal of neuroinflammation 2023; (20(1)):279 doi:10.1186/s12974-023-02952-1.

Brief digital self-care intervention for health anxiety in a Swedish Medical University Clinic: a prospective single-group feasibility study.

Österman S, Hentati A, Forsell E, et al.

BMJ open 2023; (13(12)):e077376 doi:10.1136/bmjopen-2023-077376.

Efficacy of golimumab in patients with refractory non-infectious panuveitis.

Tungsattayathitthan U, Tesavibul N, Choopong P, et al.

Scientific reports 2024; (14(1)):2179 doi:10.1038/s41598-024-52526-1.

Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening.

Giri S, Bhrugumalla S, Shukla A, et al.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2025; (26(1)):33-37 doi:10.1016/j.ajg.2024.01.013.

The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study.

Tao T, Yang S, He D, et al.

Ophthalmology and therapy 2024; (13(5)):1239-1253 doi:10.1007/s40123-024-00884-4.

Prevalence, clinical characteristics, and independent predictors of uveitic macular edema in an Asian population: a retrospective cohort study.

Tungsattayathitthan U, Jenjanya S, Choopong P, et al.

BMC ophthalmology 2024; (24(1)):181 doi:10.1186/s12886-024-03447-0.

Paediatric non-infectious granulomatous uveitis: a retrospective cohort study.

Nguyen AT, Rousseau A, Bodaghi B, et al.

Rheumatology (Oxford, England) 2025; (64(3)):1333-1340 doi:10.1093/rheumatology/keae253.

Interleukin-17A in diabetic retinopathy: The crosstalk of inflammation and angiogenesis.

Li J, Zhao T, Sun Y

Biochemical pharmacology 2024; (225()):116311 doi:10.1016/j.bcp.2024.116311.

Pattern of uveitis in a referral ophthalmology center in Northeastern Thailand.

Wannapanich T, Chuenchaem W, Luanratanakorn P, Laovirojjanakul W

Journal of ophthalmic inflammation and infection 2024; (14(1)):23 doi:10.1186/s12348-024-00400-6.

Severe Cutaneous Manifestation of Malignant Syphilis in a Patient with Behçet's Uveitis: A Case Report.

Charoenphol P, Choopong P, Sitthinamsuwan P, et al.

Case reports in ophthalmology 2024; (15(1)):335-341 doi:10.1159/000539723.

Intravitreal Dexamethasone Implant (Ozurdex) for Ocular Toxocariasis.

Zhou Y, Zhen F, Wu J, et al.

Journal of ophthalmology 2024; (2024()):6685092 doi:10.1155/2024/6685092.

Early Immunosuppressive Therapy and Ocular Complications in Pediatric and Young Adult Patients with Non-Infectious Uveitis at a Tertiary Referral Center in Japan.

Sada I, Hiyama T, Orihashi Y, et al.

Ocular immunology and inflammation 2024; (32(10)):2459-2466 doi:10.1080/09273948.2024.2409394.

Demographic Features, Diagnoses and Real-World Clinical Management of Uveitis in Japan.

Hayashi I, Keino H, Nakayama M, et al.

Ocular immunology and inflammation 2025; (33(7)):1077-1085 doi:10.1080/09273948.2024.2449179.

A Case of Vogt-Koyanagi-Harada Disease: Diagnosis Based on the Presence of Vitiligo and Sunset Glow Fundus Without Ocular Symptoms.

Tsutsui H, Fukuda K, Nakajima I, Yamashiro K

Cureus 2025; (17(1)):e78209 doi:10.7759/cureus.78209.

[VOGT-KOYANAGI-HARADA SYNDROME].

Cohen D, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Naaman E

Harefuah 2025; (164(3)):183-187.

Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis.

Uner OE, Lin P, Kopplin LJ, et al.

Ophthalmology. Retina 2025; (9(11)):1106-1113 doi:10.1016/j.oret.2025.05.006.

Therapeutic Potential of Upadacitinib in Adolescents with Idiopathic Chronic Panuveitis Who Lost Response to Adalimumab.

Guo K, Zhang X

Ocular immunology and inflammation 2025; (33(10)):2521-2525 doi:10.1080/09273948.2025.2519852.

Clinical characteristics and visual outcome of Vogt Koyanagi Harada disease patients in a specialized eye hospital in Nepal.

Bastola Paudel J, Manandhar A, Shrestha S

Journal of Nepal Health Research Council 2025; (23(1)):165-169 doi:10.33314/jnhrc.v23i01.5601.

Weekly adalimumab: A promising approach for managing refractory non-infectious chronic pediatric uveitis.

Stolowy N, Aubeleau M, Mairot K, et al.

Journal francais d'ophtalmologie 2025; (48(10)):104681 doi:10.1016/j.jfo.2025.104681.

Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First-Line Therapy.

Maccora I, Guly C, de Libero C, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2026; doi:10.1002/art.70090.